Nan-Sheng Cheng
Overview
Explore the profile of Nan-Sheng Cheng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
103
Citations
839
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zeng D, Wen N, Wang Y, Cheng N, Li B
World J Gastroenterol
. 2025 Feb;
31(6):97697.
PMID: 39958446
Background: Biliary tract cancer (BTC) is a rare, aggressive malignancy with increasing incidence and poor prognosis. Identifying preoperative prognostic factors is crucial for effective risk-benefit assessments and patient stratification. The...
2.
Cai Y, Nan F, Tang G, Ma Y, Ren Y, Xiong X, et al.
J Mater Chem B
. 2023 Sep;
11(39):9443-9458.
PMID: 37727116
In this study, a 3D porous poly(ε-caprolactone)/polyethylene glycol (PCL/PEG) composite artificial tubular bile duct was fabricated for extrahepatic bile duct regeneration. PCL/PEG composite scaffolds were fabricated by 3D printing, and...
3.
Jin Y, Ma W, Gao W, Li F, Cheng N
Surg Endosc
. 2023 Jan;
37(5):3642-3656.
PMID: 36635401
Background: The laparoscopic and open approaches have comparable safety and oncological efficacy to treat early (T1b or T2) stage incidental gallbladder cancer (IGBC). However, their effects on T3 stage or...
4.
Sun J, Cheng N
J Immunol Res
. 2022 Apr;
2022:1688460.
PMID: 35402625
As one of the most lethal forms of cancers, hepatocellular carcinoma (HCC) claims many lives around the world, and it is especially common in China. The ARID family plays key...
5.
Peng D, Nie G, Li B, Cai Y, Lu J, Xiong X, et al.
Cancer Manag Res
. 2022 Jan;
14:37-47.
PMID: 35018120
Purpose: The time-to-tumor recurrence can predict the prognosis of hepatobiliary cancers following curative-intent resection. Therefore, for patients with gallbladder carcinoma (GBC) of stage T1b-T3 who had undergone R0 resection, we...
6.
Ye X, Hu H, Xiong X, Lu J, Cheng N
Surg Today
. 2021 Mar;
51(8):1352-1360.
PMID: 33651221
Purpose: Elevated fibrinogen (Fbg) levels contribute to tumor progression and metastasis. However, little is known regarding the association of the clinicopathological characteristics and the prognosis of hilar cholangiocarcinoma (HC) with...
7.
Regmi P, Hu H, Chang-Hao Y, Liu F, Ma W, Ran C, et al.
Surg Endosc
. 2020 Nov;
35(12):6505-6512.
PMID: 33174099
Background: Surgical treatment is still the most effective treatment for gallbladder cancer. For the patients with stage T1b and above, the current guidelines recommend the extended radical operation, and oncologic...
8.
9.
Cai Y, Yang S, Peng D, Jia Q, Li F, Ye H, et al.
Medicine (Baltimore)
. 2020 Sep;
99(33):e21801.
PMID: 32872081
Acute appendicitis (AA) is the most common nonobstetric surgical emergency during pregnancy. According to the current guidelines and meta-analyses, traditional open appendectomy (OA) is still recommended for pregnant patients over...
10.
Cai Y, Lin Y, Xiong X, Ye H, Li F, Cheng N
Am J Surg
. 2020 Aug;
221(3):642-648.
PMID: 32859350
Background: The effect of postsurgical radiotherapy (PSRT) among T1-3 gallbladder cancer (GBC) patients with one to three lymph node metastases remains controversial. The aim of this study was to assess...